EDP Sciences logo
Submit your paper
Search
Menu
All issues Volume 46 / No 3 (September 2014) J Extra Corpor Technol, 46 3 (2014) 224-228 References
Free Access
Issue
J Extra Corpor Technol
Volume 46, Number 3, September 2014
Page(s) 224 - 228
DOI https://doi.org/10.1051/ject/201446224
Published online 15 September 2014
  1. Guzzetta NA, Amin SJ, Tosone AK, Miller BE. Change in the heparin potency and effects on the activated clotting time in children undergoing cardiopulmonary bypass. Anesth Analg. 2012;115:921–914. [CrossRef] [PubMed] [Google Scholar]
  2. FDA Public Health Alert. Change in Heparin US Monograph, 2010 Available at: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm184502.htm. Accessed November 12, 2012. [Google Scholar]
  3. Smythe MA, Nutescu EA, Wittkowsky AK. Changes in the USP heparin monograph and implications for clinicians. Pharmacotherapy. 2010;30:428–431. [CrossRef] [PubMed] [Google Scholar]
  4. Anderson DA, Holt DW. Has the new USP assay for heparin affected dosage for patients undergoing cardiopulmonary bypass. J Extra Corpor Technol. 2013;45:112–115. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  5. Honchel R, Carraway J, Goppe N, et al. A dose–response study in animals to evaluate the anticoagulant effect of the stage 2 unfractionated heparin USH monograph change. Regul Toxicol Pharmacol. 2011;60:318–22. [CrossRef] [Google Scholar]
  6. Guzzetta NA, Bajaj T, Fazlollah T, et al. A comparison of heparin management strategies in infants undergoing cardiopulmonary bypass. Anesth Analg. 2008;106:419–425. [CrossRef] [PubMed] [Google Scholar]
  7. Andrew M. Anticoagulation and thrombolysis in children. Tex Heart Inst J. 1992;19:168–177. [Google Scholar]
  8. Guzzetta NA, Monitz HG, Fernandez JD, et al. Correlations between activated clotting time values and heparin concentration measurements in young infants undergoing cardiopulmonary bypass. Anesth Analg. 2010;111:173–179. [CrossRef] [PubMed] [Google Scholar]
  9. Guzzetta NA, Miller BE, Todd K, et al. Clinical measures of heparin’s effect and thrombin inhibitor levels in pediatric patients with congenital heart disease. Anesth Analg. 2006;103:1131–1138. [CrossRef] [PubMed] [Google Scholar]
  10. Owings JT, Pollock ME, Gosselin RC, Ireland K, Jahr JS, Larking EC. Anticoagulation of children undergoing cardiopulmonary bypass is overestimated by current monitoring techniques. Arch Surg. 2000;135:1042–1047. [CrossRef] [Google Scholar]
  11. Gruenwald C, de Souza V, Chan AK, Andrew M. Whole blood heparin concentrations do not correlate with plasma antifactor Xa heparin concentrations in pediatric patients undergoing cardiopulmonary bypass. Perfusion. 2000;15:203–209. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.